{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:13:31Z","timestamp":1789794811494,"version":"4.0.1"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The increasing reports of xylazine in clinical and postmortem toxicology necessitate a survey of its clinical impact. This review examines reports of xylazine across the peer-reviewed literature and grey literature (government and public health reports).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>Before 2005, reports of xylazine abuse primarily involved veterinary-associated accidental and intentional exposures. A notable shift occurred in 2006 with increasing xylazine exposure documented among persons with illicit drug use, including fatal and nonfatal overdoses. Xylazine prevalence continued to increase in clinical and postmortem cases. Cases of xylazine abuse began in the northeast United States and expanded nationwide, with persistent high prevalence in the East and Midwest. Xylazine has been most frequently identified with fentanyl in clinical, drug-impaired driving, and postmortem analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Xylazine\u2019s rising prevalence, especially as a fentanyl adulterant, contributes to increased opioid-related morbidity and mortality. Its presence across clinical, forensic, and environmental samples underscores the urgent need for enhanced surveillance, clinician education, public awareness, and targeted policy responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf147","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:02Z","timestamp":1762875962000},"page":"347-366","source":"Crossref","is-referenced-by-count":1,"title":["Emerging Threat of Xylazine"],"prefix":"10.1093","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6780-6612","authenticated-orcid":false,"given":"Kyla M","family":"Jorgenson","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Middleberg","sequence":"additional","affiliation":[{"name":"NMS Labs , Horsham, PA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy L","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-1882","authenticated-orcid":false,"given":"Alex J","family":"Krotulski","sequence":"additional","affiliation":[{"name":"Center for Forensic Science Research & Education, Fredric Rieders Family Foundation , Horsham, PA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E","family":"Nacca","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Rochester Medical Center , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-0229","authenticated-orcid":false,"given":"Tanzy M","family":"Love","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, University of Rochester , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Marvald","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, University of Rochester , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Becker","sequence":"additional","affiliation":[{"name":"Edward G. Miner Library, University of Rochester Medical Center , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2137-4645","authenticated-orcid":false,"given":"Marilyn A","family":"Huestis","sequence":"additional","affiliation":[{"name":"Institute of Emerging Health Professions, Thomas Jefferson University , Philadelphia, PA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Victoria","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center , Rochester, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2026030508530516900_hvaf147-B1","volume-title":"Xylazine","author":"Drug Enforcement Administration","year":"2021"},{"key":"2026030508530516900_hvaf147-B2","author":"United Nations: Office on Drugs and Crime"},{"key":"2026030508530516900_hvaf147-B3","doi-asserted-by":"crossref","first-page":"109380","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"2026030508530516900_hvaf147-B4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/15563657908989878","article-title":"Xylazine hydrochloridine (rompun) overdose in man","volume":"15","author":"Carruthers","year":"1979","journal-title":"Clin Toxicol"},{"key":"2026030508530516900_hvaf147-B5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/15563658108990293","article-title":"Human xylazine overdose: a comparative review with clonidine, phenothiazines, and tricyclic antidepressants","volume":"18","author":"Gallanosa","year":"1981","journal-title":"Clin Toxicol"},{"key":"2026030508530516900_hvaf147-B6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/bmj.287.6402.1369","article-title":"Clinical curio: self medication with xylazine","volume":"287","author":"Lewis","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2026030508530516900_hvaf147-B7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jat\/9.5.234","article-title":"Xylazine in human tissue and fluids in a case of fatal drug abuse","volume":"9","author":"Poklis","year":"1985","journal-title":"J Anal Toxicol"},{"key":"2026030508530516900_hvaf147-B8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0735-6757(86)90070-7","article-title":"Human overdose with the veterinary tranquilizer xylazine","volume":"4","author":"Spoerke","year":"1986","journal-title":"Am J Emerg Med"},{"key":"2026030508530516900_hvaf147-B9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/pgmj.66.773.244","article-title":"Accidental self administration of xylazine in a veterinary nurse","volume":"66","author":"Samanta","year":"1990","journal-title":"Postgrad Med J"},{"key":"2026030508530516900_hvaf147-B10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006565-200112000-00012","article-title":"Severe intoxication from xylazine inhalation","volume":"17","author":"Capraro","year":"2001","journal-title":"Pediatr Emerg Care"},{"key":"2026030508530516900_hvaf147-B11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jat\/25.4.245","article-title":"Severe intoxication with the veterinary tranquilizer xylazine in humans","volume":"25","author":"Hoffmann","year":"2001","journal-title":"J Anal Toxicol"},{"key":"2026030508530516900_hvaf147-B12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jat\/27.2.110","article-title":"Tissue distribution of xylazine in a suicide by hanging","volume":"27","author":"Moore","year":"2003","journal-title":"J Anal Toxicol"},{"key":"2026030508530516900_hvaf147-B13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0379-0738(03)00083-5","article-title":"A reported case involving impaired driving following self-administration of xylazine","volume":"134","author":"Stillwell","year":"2003","journal-title":"Forensic Sci Int"},{"key":"2026030508530516900_hvaf147-B14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1556-4029.2007.00648.x","article-title":"Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia medical examiner\u2019s office","volume":"53","author":"Wong","year":"2008","journal-title":"J Forensic Sci"},{"key":"2026030508530516900_hvaf147-B15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/15563650601073520","article-title":"Xylazine abuse: a rare cause of syncope","volume":"45","author":"Liu","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"2026030508530516900_hvaf147-B16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/dta.1475","article-title":"Case report of accidental poisoning with the tranquilizer xylazine and the anesthetic ketamine confirmed by qualitative and quantitative toxicological analysis using GC-MS and LC-MSn","volume":"5","author":"Meyer","year":"2013","journal-title":"Drug Test Anal"},{"key":"2026030508530516900_hvaf147-B17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1556-4029.13270","article-title":"Attempted drug-facilitated sexual assault\u2014xylazine intoxication in a child","volume":"62","author":"Andresen-Streichert","year":"2017","journal-title":"J Forensic Sci"},{"key":"2026030508530516900_hvaf147-B18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/1556-4029.13684","article-title":"Use of xylazine in drug-facilitated crimes","volume":"63","author":"Krongvorakul","year":"2018","journal-title":"J Forensic Sci"},{"key":"2026030508530516900_hvaf147-B19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PAF.0000000000000910","article-title":"A series of 8 illicit fentanyl intoxication deaths in infants and toddlers","volume":"45","author":"Vincent","year":"2024","journal-title":"Am J Forensic Med Pathol"},{"key":"2026030508530516900_hvaf147-B20","doi-asserted-by":"crossref","first-page":"102542","DOI":"10.1016\/j.jflm.2023.102542","article-title":"The first drug-related death associated with xylazine use in the UK and Europe","volume":"97","author":"Rock","year":"2023","journal-title":"J Forensic Leg Med"},{"key":"2026030508530516900_hvaf147-B21","doi-asserted-by":"crossref","first-page":"1437960","DOI":"10.3389\/fphar.2024.1437960","article-title":"Fatal hyperpyrexia caused by xylazine: a case report","volume":"15","author":"Dai","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026030508530516900_hvaf147-B22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/jalm\/jfac083","article-title":"An epidemic within a pandemic: an 8-year-old boy with xylazine-complicating fentanyl poisoning, and drug detection challenges","volume":"7","author":"Gill","year":"2022","journal-title":"J Appl Lab Med"},{"key":"2026030508530516900_hvaf147-B23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ADM.0000000000000955","article-title":"Management of xylazine xithdrawal in a hospitalized patient: a case report","volume":"16","author":"Ehrman-Dupre","year":"2022","journal-title":"J Addict Med"},{"key":"2026030508530516900_hvaf147-B24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/tjem.tjem_198_22","article-title":"A case series of accidental xylazine intoxication in humans; is there a role of naloxone as an antidote?","volume":"23","author":"Choon","year":"2023","journal-title":"Turk J Emerg Med"},{"key":"2026030508530516900_hvaf147-B25","doi-asserted-by":"crossref","first-page":"e2022058684","DOI":"10.1542\/peds.2022-058684","article-title":"Xylazine complicating opioid ingestions in young children","volume":"151","author":"Deutsch","year":"2023","journal-title":"Pediatrics"},{"key":"2026030508530516900_hvaf147-B26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12954-024-00978-z","article-title":"A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA","volume":"21","author":"Warp","year":"2024","journal-title":"Harm Reduct J"},{"key":"2026030508530516900_hvaf147-B27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jalm\/jfad119","article-title":"Not carfentanil-a case of unexpected xylazine detection","volume":"9","author":"Zheng","year":"2024","journal-title":"J Appl Lab Med"},{"key":"2026030508530516900_hvaf147-B28","doi-asserted-by":"crossref","first-page":"e14512","DOI":"10.1111\/1742-6723.14512","article-title":"A cluster of multi-drug intoxications involving xylazine, benzimidazole opioids (nitazenes) and novel benzodiazepines in South Australia","volume":"37","author":"Partridge","year":"2024","journal-title":"Emerg Med Australas"},{"key":"2026030508530516900_hvaf147-B29","doi-asserted-by":"crossref","first-page":"119826","DOI":"10.1016\/j.cca.2024.119826","article-title":"\u201cTranq-dope\u201d: the first fatal intoxication due to xylazine-adulterated heroin in Italy","volume":"561","author":"Di Trana","year":"2024","journal-title":"Clin Chim Acta"},{"key":"2026030508530516900_hvaf147-B30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jat\/bkac049","article-title":"Xylazine: pharmacology review and prevalence and drug combinations in forensic toxicology casework","volume":"46","author":"Kacinko","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026030508530516900_hvaf147-B31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12954-023-00782-1","article-title":"Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs","volume":"20","author":"Daniulaityte","year":"2023","journal-title":"Harm Reduct J"},{"key":"2026030508530516900_hvaf147-B32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the United States in healthcare patient samples","volume":"17","author":"Holt","year":"2023","journal-title":"J Addict Med"},{"key":"2026030508530516900_hvaf147-B33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650.2022.2159427","article-title":"Opioid overdoses involving xylazine in emergency department patients: a multicenter study","volume":"61","author":"Love","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"2026030508530516900_hvaf147-B34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clinica Chimica Acta"},{"key":"2026030508530516900_hvaf147-B35","doi-asserted-by":"crossref","first-page":"100209","DOI":"10.1016\/j.dadr.2023.100209","article-title":"Prevalence of xylazine among people who inject drugs seeking medical care at a syringe services program clinic: Miami, Florida, 2023","volume":"9","author":"Hauschild","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"key":"2026030508530516900_hvaf147-B36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15563650.2024.2309321","article-title":"N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom","volume":"62","author":"Pucci","year":"2024","journal-title":"Clin Toxicol (Phila)"},{"key":"2026030508530516900_hvaf147-B37","doi-asserted-by":"publisher","author":"Friedman","DOI":"10.1101\/2024.08.19.24312273"},{"key":"2026030508530516900_hvaf147-B38","doi-asserted-by":"crossref","first-page":"1127020","DOI":"10.3389\/fped.2023.1127020","article-title":"Analysis of umbilical cord tissue as an indicator of in utero exposure to toxic adulterating substances","volume":"11","author":"Midthun","year":"2023","journal-title":"Front Pediatr"},{"key":"2026030508530516900_hvaf147-B39","author":"The Center for Forensic Science Research and Education"},{"key":"2026030508530516900_hvaf147-B40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"2026030508530516900_hvaf147-B41","author":"Centers for Disease Control and Prevention"},{"key":"2026030508530516900_hvaf147-B42","author":"California Department of Public Health"},{"key":"2026030508530516900_hvaf147-B43","author":"Connecticut Department of Public Health"},{"key":"2026030508530516900_hvaf147-B44","author":"Mason"},{"key":"2026030508530516900_hvaf147-B45","author":"Louisiana Department of Health"},{"key":"2026030508530516900_hvaf147-B46","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/15563650.2023.2288540","article-title":"Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program","volume":"61","author":"Vohra","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"2026030508530516900_hvaf147-B47","author":"Ohio Department of Health"},{"key":"2026030508530516900_hvaf147-B48","author":"Texas Health Data"},{"key":"2026030508530516900_hvaf147-B49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ajad.13365","article-title":"Characteristics of xylazine-related deaths in West Virginia-xylazine-related deaths","volume":"32","author":"Sibbesen","year":"2023","journal-title":"Am J Addict"},{"key":"2026030508530516900_hvaf147-B50","author":"Florida Medical Examiners Commission"},{"key":"2026030508530516900_hvaf147-B51","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/1556-4029.15375","article-title":"Prevalence of xylazine in overdose cases: an analysis of Miami-dade county medical examiner case data","volume":"68","author":"Potoukian","year":"2023","journal-title":"J Forensic Sci"},{"key":"2026030508530516900_hvaf147-B52","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/1556-4029.15596","article-title":"Prevalence of fentanyl in the pediatric postmortem population from 2019 to 2023","volume":"69","author":"Peterson","year":"2024","journal-title":"J Forensic Sci"},{"key":"2026030508530516900_hvaf147-B53","doi-asserted-by":"crossref","first-page":"e0292674","DOI":"10.1371\/journal.pone.0292674","article-title":"Postmortem toxicology findings from the Camden Opioid Research Initiative","volume":"18","author":"Kusic","year":"2023","journal-title":"PLoS One"},{"key":"2026030508530516900_hvaf147-B54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-024-00959-2","article-title":"Xylazine co-occurrence with illicit fentanyl is a growing threat in the deep south: a retrospective study of decedent data","volume":"21","author":"Bradford","year":"2024","journal-title":"Harm Reduct J"},{"key":"2026030508530516900_hvaf147-B55","doi-asserted-by":"crossref","first-page":"e2324001","DOI":"10.1001\/jamanetworkopen.2023.24001","article-title":"Xylazine-involved fatal and nonfatal drug overdoses in Tennessee from 2019 to 2022","volume":"6","author":"Korona-Bailey","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026030508530516900_hvaf147-B56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine\u2014United States, January 2019-June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15563650.2024.2309326","article-title":"Evaluation of the relationship of xylazine and fentanyl blood concentrations among fentanyl-associated fatalities","volume":"62","author":"Hays","year":"2024","journal-title":"Clin Toxicol (Phila)"},{"key":"2026030508530516900_hvaf147-B58","author":"New York City Department of Health and Mental Hygiene"},{"key":"2026030508530516900_hvaf147-B59","author":"Georgia Department of Public Health: Drug Surveillance Unit"},{"key":"2026030508530516900_hvaf147-B60","author":"Drug Overdose Prevention\u2014Injury and Violence Prevention Section"},{"key":"2026030508530516900_hvaf147-B61","author":"Oregon Health Authority"},{"key":"2026030508530516900_hvaf147-B62","author":"Vermont Department of Health"},{"key":"2026030508530516900_hvaf147-B63","doi-asserted-by":"crossref","first-page":"104154","DOI":"10.1016\/j.drugpo.2023.104154","article-title":"Xylazine in the drug supply: emerging threats and lessons learned in areas with high levels of adulteration","volume":"120","author":"Quijano","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2026030508530516900_hvaf147-B64","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.15585\/mmwr.mm7037a5","article-title":"Notes from the field: xylazine, a veterinary tranquilizer, identified as an emerging novel substance in drug overdose deaths - Connecticut, 2019-2020","volume":"70","author":"Thangada","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B65","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm7037a4","article-title":"Notes from the field: xylazine detection and involvement in drug overdose deaths - United States, 2019","volume":"70","author":"Kariisa","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.15585\/mmwr.mm7113a3","article-title":"Notes from the field: xylazine-related deaths\u2014Cook County, Illinois, 2017-2021","volume":"71","author":"Chhabra","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B67","doi-asserted-by":"crossref","first-page":"110833","DOI":"10.1016\/j.drugalcdep.2023.110833","article-title":"Xylazine-involved fatal overdoses and localized geographic clustering: Cook County, IL, 2019-2022","volume":"249","author":"Delcher","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"2026030508530516900_hvaf147-B68","article-title":"Drug overdose deaths involving xylazine: United States, 2018\u20132021","volume":"30","author":"Spencer","year":"2023","journal-title":"Vital Statistics Rapid Release"},{"key":"2026030508530516900_hvaf147-B69","author":"Missouri Department of Health and Senior Services"},{"key":"2026030508530516900_hvaf147-B70","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1080\/10826084.2024.2393220","article-title":"Modeling changes of fatal xylazine-involved drug overdoses in Connecticut across time","volume":"59","author":"Thuillier","year":"2024","journal-title":"Subst Use Misuse"},{"key":"2026030508530516900_hvaf147-B71","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1080\/10826084.2025.2497951","article-title":"Substance use monitoring among people who use drugs using a novel assay to test dried blood spot specimens","volume":"60","author":"Zinsli","year":"2025","journal-title":"Subst Use Misuse"},{"key":"2026030508530516900_hvaf147-B72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/ajad.13506","article-title":"Youth fatal drug overdose and suicide: trends in Connecticut, 2019-2021","volume":"33","author":"Kaminer","year":"2024","journal-title":"Am J Addict"},{"key":"2026030508530516900_hvaf147-B73","author":"Tennessee Department of Health: Office of Informatics and Analytics"},{"key":"2026030508530516900_hvaf147-B74","author":"North Dakota Department of Health and Human Services"},{"key":"2026030508530516900_hvaf147-B75","author":"DEA Joint Intelligence Report"},{"key":"2026030508530516900_hvaf147-B76","author":"Government of the District of Columbia: Office of the Chief Medical Examiner"},{"key":"2026030508530516900_hvaf147-B77","author":"Alabama Operations Center\/Gulf Coast HIDTA"},{"key":"2026030508530516900_hvaf147-B78","author":"Massachusetts Department of Public Health"},{"key":"2026030508530516900_hvaf147-B79","author":"Vermont Department of Health"},{"key":"2026030508530516900_hvaf147-B80","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC-MS confirmation of xylazine (rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodr\u00edguez","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"2026030508530516900_hvaf147-B81","author":"National Forensic Laboratory Information System"},{"key":"2026030508530516900_hvaf147-B82","author":"Diversion Control Division"},{"key":"2026030508530516900_hvaf147-B83","author":"The Center for Forensic Science Research and Education"},{"key":"2026030508530516900_hvaf147-B84","doi-asserted-by":"crossref","first-page":"111083","DOI":"10.1016\/j.forsciint.2021.111083","article-title":"Analysis of drug residue in needle-exchange syringes in Washington, D.C","volume":"329","author":"Evans","year":"2021","journal-title":"Forensic Sci Int"},{"key":"2026030508530516900_hvaf147-B85","doi-asserted-by":"crossref","first-page":"104118","DOI":"10.1016\/j.drugpo.2023.104118","article-title":"Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island","volume":"118","author":"Collins","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2026030508530516900_hvaf147-B86","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm7217a2","article-title":"Rapid analysis of drugs: a pilot surveillance system to detect changes in the illicit drug supply to guide timely harm reduction responses\u2014eight syringe services programs, Maryland, November 2021-August 2022","volume":"72","author":"Russell","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B87","doi-asserted-by":"crossref","first-page":"204","DOI":"10.31389\/jied.122","article-title":"Potency-enhancing synthetics in the drug overdose epidemic: xylazine (\u201ctranq\u201d), fentanyl, methamphetamine, and the displacement of heroin in Philadelphia and Tijuana","volume":"4","author":"Montero","year":"2022","journal-title":"J Illicit Econ Dev"},{"key":"2026030508530516900_hvaf147-B88","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J Urban Health"},{"key":"2026030508530516900_hvaf147-B89","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/ADM.0000000000001264","article-title":"Xylazine use among people who inject drugs, Philadelphia 2022","volume":"18","author":"Tan","year":"2024","journal-title":"J Addict Med"},{"key":"2026030508530516900_hvaf147-B90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12954-024-00940-z","article-title":"Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore","volume":"21","author":"German","year":"2024","journal-title":"Harm Reduct J"},{"key":"2026030508530516900_hvaf147-B91","doi-asserted-by":"crossref","first-page":"594","DOI":"10.15585\/mmwr.mm7326a2","article-title":"Reported xylazine use among adults aged \u226518 years evaluated for substance use treatment\u2014United States, July 2022-September 2023","volume":"73","author":"Jiang","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ADM.0000000000001216","article-title":"Self-reported xylazine experiences: a mixed-methods study of Reddit subscribers","volume":"17","author":"Spadaro","year":"2023","journal-title":"J Addict Med"},{"key":"2026030508530516900_hvaf147-B93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12954-024-00995-y","article-title":"Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont","volume":"21","author":"Erath","year":"2024","journal-title":"Harm Reduct J"},{"key":"2026030508530516900_hvaf147-B94","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.dadr.2024.100247","article-title":"Xylazine awareness, desire, use and exposure: preliminary findings from the Rhode Island community-based drug checking cohort study","volume":"11","author":"Park","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"key":"2026030508530516900_hvaf147-B95","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.focus.2024.100203","article-title":"Wastewater surveillance for xylazine in Kentucky","volume":"3","author":"Delcher","year":"2024","journal-title":"AJPM Focus"},{"key":"2026030508530516900_hvaf147-B96","doi-asserted-by":"crossref","first-page":"108416","DOI":"10.1016\/j.drugalcdep.2020.108416","article-title":"Fentanyl and fentanyl analogs in the illicit stimulant supply: results from U.S. Drug seizure data, 2011-2016","volume":"218","author":"Park","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2026030508530516900_hvaf147-B97","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019-2020","volume":"70","author":"O'Donnell","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030508530516900_hvaf147-B98","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1097\/PHH.0000000000001581","article-title":"Implementation and uptake of the Massachusetts drug supply data stream: a statewide public health-public safety partnership drug checking program","volume":"28","author":"Green","year":"2022","journal-title":"J Public Health Manag Pract"},{"key":"2026030508530516900_hvaf147-B99","volume-title":"Xylazine response among harm reduction organizations","author":"Oliver","year":"2024"},{"key":"2026030508530516900_hvaf147-B100","author":"US Executive Office of the President: Office of National Drug Control Policy"},{"key":"2026030508530516900_hvaf147-B101","author":"US Executive Office of the President: Office of National Drug Control Policy"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/3\/347\/65269966\/hvaf147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/3\/347\/65269966\/hvaf147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:53:20Z","timestamp":1772718800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/3\/347\/8320600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,11]]},"published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf147","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,11]]}}}